Also featured in Nature Middle East News Article.
Check out our latest publication in Nature Biomedical Engineering where we leverage high-throughput microfluidics and phenotypic genome-wide CRISPER screens to discover a new druggable target for cancer therapy.
Professor Dingjiang Xue has attracted Excellent Youth Scientists Funding from National Natural Science Foundation of China. Prof. Xue is a Visiting Professor in the Sargent Group; he is an Associate Professor at the Institute of Chemistry, Chinese Academy of Sciences.